[Consensus document on tuberculosis prevention and control in Spain. Research Unit on Tuberculosis of Barcelona (UITB). Area of Tuberculosis and Respiratory Infections (TIR) of the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) and Study Group on Aids (GESIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)].
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000517:prevention & control; D000328:Adult; D000437:Alcoholism / Q000150:complications; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001500:BCG Vaccine / Q000008:administration & dosage; D002648:Child; D016358:Contact Tracing; D018563:Disease Notification; D005260:Female; D006760:Hospitalization; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D008297:Male; D009293:Opioid-Related Disorders / Q000150:complications; D011159:Population Surveillance; D015995:Prevalence; D012042:Registries; D012307:Risk Factors; D013997:Time Factors; D014374:Tuberculin Test; D014376:Tuberculosis / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D014611:Vaccination; D014944:World Health Organization
D019380:Anti-HIV Agents; D000995:Antitubercular Agents; D001500:BCG Vaccine